Natera, Inc.(NTRA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,382 of 2,961 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
NTRA Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Natera, Inc. (NTRA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NTRA at 53.5/100 on a 32-signal composite quality model, placing it at rank #1,382 of 2,961 stocks — the top half of the AI-ranked universe. NTRA scores in the top quartile across revenue growth (92.6). Areas of concern include balance sheet strength (18.3) and profitability (30.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 11.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Natera, Inc. reports quarterly revenue of $752.8M, net income of $-67.0M, an operating margin of -10.1%. Top institutional holders of NTRA by reported 13-F value include JPMORGAN CHASE, BlackRock, PRICE T ROWE ASSOCIATES, based on the most recent SEC filings. NTRA trades on the Nasdaq exchange and files with the SEC under CIK 1604821. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NTRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Natera, Inc. directly from SEC EDGAR. Natera, Inc.'s 13F Pro composite quality score has ranged between 30 and 54 since 2021, currently 53.5 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$752.8M
Net Income
Q2 2026
$-67.0M
Free Cash Flow
Q2 2026
$-8.6M
Operating Margin
Q2 2026
-10.1%
ROIC
Q2 2026
-15.9%
D/E Ratio
Q2 2026
0.04
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+35.9% YoYNet Income
-9.3% YoYOperating Income
-39.4% YoYEPS (Diluted)
+0.7% YoYTotal Assets
+44.4% YoYTotal Debt
-0.0% YoYOp. Cash Flow
+58.7% YoYFree Cash Flow
+57.6% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.31B +35.9% | $1.70B +56.7% | $1.08B +32.0% | $820.2M +31.1% | $625.5M +60.0% | $391.0M |
| Net Income | $-208.2M -9.3% | $-190.4M +56.2% | $-434.8M +20.6% | $-547.8M -16.1% | $-471.7M -105.3% | $-229.7M |
| Operating Income | $-309.9M -39.4% | $-222.3M +50.2% | $-446.2M +17.5% | $-541.0M -15.6% | $-468.2M -116.5% | $-216.3M |
| EPS (Diluted) | $-1.52 +0.7% | $-1.53 +59.5% | $-3.78 +32.1% | $-5.57 -6.9% | $-5.21 -83.5% | $-2.84 |
| Total Assets | $2.40B +44.4% | $1.66B +15.2% | $1.44B +3.4% | $1.39B +12.8% | $1.24B +32.6% | $932.2M |
| Total Debt | $80.3M -0.0% | $80.4M -77.9% | $363.3M +0.4% | $362.0M +9.5% | $330.4M +560.2% | $50.1M |
| Operating Cash Flow | $215.3M +58.7% | $135.7M +154.9% | $-247.0M +42.8% | $-431.5M -28.7% | $-335.2M -83.7% | $-182.5M |
| Free Cash Flow | $109.1M +57.6% | $69.2M +124.2% | $-286.2M +40.3% | $-479.2M -27.4% | $-376.3M -86.2% | $-202.1M |
Get alerted when NTRA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Natera, Inc. including:
Top Institutional Holders of NTRA
JPMORGAN CHASE & CO
$3.5B12,865,346 shBlackRock, Inc.
$3.0B10,914,608 shPRICE T ROWE ASSOCIATES INC /MD/
$2.4B9,021,895 shVANGUARD CAPITAL MANAGEMENT LLC
$1.7B6,228,216 shVANGUARD PORTFOLIO MANAGEMENT LLC
$1.6B5,782,640 shFMR LLC
$1.5B5,451,396 shWELLINGTON MANAGEMENT GROUP LLP
$1.1B4,040,738 shSTATE STREET CORP
$992.3M3,655,618 shDuquesne Family Office LLC
$864.9M3,186,306 shGEODE CAPITAL MANAGEMENT, LLC
$744.6M2,750,013 sh
| Fund | Value | Shares |
|---|---|---|
| JPMORGAN CHASE & CO | $3.5B | 12,865,346 |
| BlackRock, Inc. | $3.0B | 10,914,608 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $2.4B | 9,021,895 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.7B | 6,228,216 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.6B | 5,782,640 |
| FMR LLC | $1.5B | 5,451,396 |
| WELLINGTON MANAGEMENT GROUP LLP | $1.1B | 4,040,738 |
| STATE STREET CORP | $992.3M | 3,655,618 |
| Duquesne Family Office LLC | $864.9M | 3,186,306 |
| GEODE CAPITAL MANAGEMENT, LLC | $744.6M | 2,750,013 |
Companies Similar to NTRA
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
INSMED Inc
Axsome Therapeutics, Inc.
Guardant Health, Inc.
Adaptive Biotechnologies Corp
GLAUKOS Corp
ARROWHEAD PHARMACEUTICALS, INC.
Hims & Hers Health, Inc.
COOPER COMPANIES, INC.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put NTRA on your watchlist
Track score changes the day Natera, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NTRA a good stock to buy?
13F Pro's AI-powered analysis of Natera, Inc. (NTRA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NTRA are available on the NTRA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NTRA is classified as a large company.
Which hedge funds own NTRA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NTRA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Natera, Inc.'s investment landscape.